Navigation Links
Facet Solutions Completes 1 Year Follow-up on U.S. Pilot Study
Date:4/23/2009

HOPKINTON, Mass., April 23 /PRNewswire/ -- Facet Solutions, Inc. today announced the publication of its one-year data for the ACADIA(TM) U.S. Pilot Clinical Study. The study utilized the ACADIA(TM) Facet Replacement System for the treatment of lumbar spinal stenosis. The results showed dramatic improvements across all measures, including an 88% reduction in Oswestry Disability Index, a 77% reduction in back pain, and an 83% reduction in leg pain. There were no device-related adverse events in any of the patients.

"The results continue to be impressive," commented Dr. John Regan (St. John's Hospital, Santa Monica, CA), who is the principal investigator for the ACADIA(TM) stenosis study. "Facet replacement surgery will offer stenosis patients who currently undergo lumbar fusion a compelling motion preservation option to address both pain and function."

Facet Solutions' President & CEO Geoff Pardo added, "These results have exceeded our expectations and provide us with further confidence that this important technology will provide significant patient benefits. Patients and surgeons tell us they want a lumbar spine solution which provides pain relief and anatomic motion, and we think we have that solution." Facet Solutions, Inc. is currently enrolling patients in its Multi-center Pivotal Study in the United States.

One year data from Facet Solutions' U.S. Pilot Study will be presented at the upcoming Spine Arthroplasty Society meeting (SAS9) to be held April 27th-May 1st, 2009 in London, England.

*Note: ACADIA(TM) is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet Solutions has received venture capital from its partners DeNovo Ventures, FirstMark Capital, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485.


'/>"/>
SOURCE Facet Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
2. Journal of Alzheimers Disease special issue explores multifaceted aspects of AD
3. Facet Solutions, Inc. Expands Executive Management Team
4. Facet Solutions, Inc. Appoints Industry Veteran to Board of Directors
5. Facet Solutions, Inc. Completes Combination Facet Joint and Disc Replacement Study
6. TruFUSE(R) Minimally Invasive Facet Fusion Procedure Tops 3,000 Spinal Levels
7. Facet joint effusion and interspinal ligament edema: major sources of lower back pain
8. Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
9. Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
10. The Help Group Launches Multifaceted Autism Awareness Campaign
11. Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... Sept. 12, 2017  Consumer reviews on the independent review site ... the number one company for hearing aids, ranking it higher than ... brands. ... #1 by Consumers For Hearing Aids ... Hearing is an online store that provides high performance, state-of-the-art, German-engineered ...
Breaking Medicine Technology: